Search | TVST | ARVO Journals

Showing 1 – 20 of 45

SORT: Best Match Most Recent Oldest

VIEW: Basic | Expanded

ARVO Annual Meeting Abstract June 2021

Safety of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders

Sumit Sharma; Allen Hu; Colette Hall; Barry Kapik; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1209. doi:

ARVO Annual Meeting Abstract June 2021

Suprachoroidally delivered DNA nanoparticles produce human Myosin7A protein in RPE-choroid in rabbits

Viral Kansara; Mark J Cooper; Leroy Muya; Robert Moen; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1200. doi:

ARVO Annual Meeting Abstract June 2021

Ophthalmic Procedure Training During COVID-19: Virtual and In-Person Training of the Suprachoroidal Injection Procedure

Nathan Fisher; Shelley Hancock; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1190. doi:

ARVO Annual Meeting Abstract June 2021

Uveitic Macular Edema: OCT Anatomic and Temporal Biomarkers

Debra A Goldstein; Barry Kapik; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1933. doi:

ARVO Annual Meeting Abstract June 2021

Vertical Transect Analysis of Optical Coherence Tomography Images in Patients Treated for Diabetic Macular Edema

Jeffrey Eng; Nathan Lowry; Rivka Strelnikov; Thomas A Ciulla; Michael S Ip

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1786. doi:

ARVO Annual Meeting Abstract June 2021

Long-acting potential of suprachoroidally delivered BCX4161, a selective plasma kallikrein inhibitor, for diabetic macular edema

Leroy Muya; Yahya El-Kattan; Viral Kansara; Yarlagadda Babu; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2194. doi:

ARVO Annual Meeting Abstract June 2021

Diurnal optic nerve head blood flow biomarker differences between male and female subjects with and without glaucoma measured by optical coherence tomography angiography

Ryan Zukerman; Alon Harris; Francesco Oddone; Brent A Siesky; Richard B Rosen; Thomas A Ciulla; George Eckert; Lucas William Rowe; Alice Chandra Verticchio Vercellin

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):2574. doi:

ARVO Annual Meeting Abstract June 2021

Post hoc Analysis of Clinical Suprachoroidal Injection Experience for Non-infectious Uveitis

Milan Shah; Cherry Wan; Barry Kapik; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1192. doi:

ARVO Annual Meeting Abstract June 2021

Longer term Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular AMD, Diabetic Macular Edema and Retina Vein Occlusion–Related Macular Edema: A Real World Analysis of 130,247 Patient Eyes

Thomas A Ciulla; John Pollack; David Williams

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):452. doi:

ARVO Annual Meeting Abstract June 2021

Suprachoroidal Injections Across Species Analyzed via Multimodal Imaging

Allen Ho; Cherry Wan; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2021; 62(8):1179. doi:

Articles June 2021

Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits

PDF

Viral S. Kansara; Leroy W. Muya; Thomas A. Ciulla
TAGS: axitinib, oryctolagus cuniculus, subcutaneous injections, patient disposition, eye
Trans. Vis. Sci. Tech.. 2021; 10(7):19. doi: https://doi.org/10.1167/tvst.10.7.19

Includes: Supplemental Content

Articles December 2020

Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in Rabbits

PDF

Viral S. Kansara; Mark Cooper; Ozge Sesenoglu-Laird; Leroy Muya; Robert Moen; Thomas A. Ciulla

Trans. Vis. Sci. Tech.. 2020; 9(13):21. doi: https://doi.org/10.1167/tvst.9.13.21

Articles October 2020

Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders

PDF

Chen-rei Wan; Barry Kapik; Charles C. Wykoff; Christopher R. Henry; Mark R. Barakat; Milan Shah; Rafael V. Andino; Thomas A. Ciulla
TAGS: injections, needles, retinal diseases, subcutaneous injections, surveys
Trans. Vis. Sci. Tech.. 2020; 9(11):27. doi: https://doi.org/10.1167/tvst.9.11.27

ARVO Annual Meeting Abstract June 2020

Correlation of Best Corrected Visual Acuity and Central Subfield Thickness in Macular Edema Due to Retinal Vein Occlusion, Diabetic Retinopathy and Uveitis

Dilraj Grewal; Thomas A Ciulla; Barry Kapik

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3239. doi:

ARVO Annual Meeting Abstract June 2020

Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Macular Edema Due to Retinal Vein Occlusion: A Real World Analysis of 12,214 Eyes.

Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3523. doi:

ARVO Annual Meeting Abstract June 2020

Ocular Pharmacokinetics and Safety of Suprachoroidal A01017, Small Molecule Complement Inhibitor, Injectable Suspension in Rabbits

Shelley E Hancock; Avinash Phadke; Viral Kansara; David Boyer; Jose Rivera; Christopher Marlor; Steven Podos; Jason Wiles; Rick McElheny; Thomas A Ciulla; Mingjun Huang; Mark Cartwright

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):3694. doi:

ARVO Annual Meeting Abstract June 2020

A Lean Six Sigma Approach to Scleral Buckling Surgery

Michael Gemayel; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4380. doi:

ARVO Annual Meeting Abstract June 2020

Area of Disorganization of the Retinal Inner Layers (DRIL) as a Quantitative Biomarker in Eyes with Diabetic Macular Edema

Swetha Bindu Velaga; Muneeswar Gupta Nittala; Jyotsna Maram; Thomas A Ciulla; Michael S Ip; Srinivas Sadda

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4859. doi:

ARVO Annual Meeting Abstract June 2020

Treatment Burden and Visual Outcomes in Neovascular Age-Related Macular Degeneration (AMD)

Saira Khanna; Rahul Komati; David Aaron Eichenbaum; Ishani Hariprasad; Thomas A Ciulla; Seenu Hariprasad

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):4200. doi:

ARVO Annual Meeting Abstract June 2020

Suprachoroidal Delivery of Suspensions of Tyrosine Kinase Inhibitor, Complement Inhibitor, and Corticosteroid: Preclinical and Clinical Correlates

Debra A Goldstein; Thomas A Ciulla

Invest. Ophthalmol. Vis. Sci.. 2020; 61(7):2898. doi:

1 2 3

Next 20 Results »

NARROW

Content Type

Journal

Article Type

Topics

Tags

Specify Date Range

Safety of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders

Suprachoroidally delivered DNA nanoparticles produce human Myosin7A protein in RPE-choroid in rabbits

Ophthalmic Procedure Training During COVID-19: Virtual and In-Person Training of the Suprachoroidal Injection Procedure

Uveitic Macular Edema: OCT Anatomic and Temporal Biomarkers

Vertical Transect Analysis of Optical Coherence Tomography Images in Patients Treated for Diabetic Macular Edema

Long-acting potential of suprachoroidally delivered BCX4161, a selective plasma kallikrein inhibitor, for diabetic macular edema

Diurnal optic nerve head blood flow biomarker differences between male and female subjects with and without glaucoma measured by optical coherence tomography angiography

Post hoc Analysis of Clinical Suprachoroidal Injection Experience for Non-infectious Uveitis

Longer term Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Neovascular AMD, Diabetic Macular Edema and Retina Vein Occlusion–Related Macular Edema: A Real World Analysis of 130,247 Patient Eyes

Suprachoroidal Injections Across Species Analyzed via Multimodal Imaging

Evaluation of Long-Lasting Potential of Suprachoroidal Axitinib Suspension Via Ocular and Systemic Disposition in Rabbits

Suprachoroidally Delivered DNA Nanoparticles Transfect Retina and Retinal Pigment Epithelium/Choroid in Rabbits

Clinical Characterization of Suprachoroidal Injection Procedure Utilizing a Microinjector across Three Retinal Disorders

Correlation of Best Corrected Visual Acuity and Central Subfield Thickness in Macular Edema Due to Retinal Vein Occlusion, Diabetic Retinopathy and Uveitis

Visual Acuity Outcomes and Anti-Vascular Endothelial Growth Factor Therapy Intensity in Macular Edema Due to Retinal Vein Occlusion: A Real World Analysis of 12,214 Eyes.

Ocular Pharmacokinetics and Safety of Suprachoroidal A01017, Small Molecule Complement Inhibitor, Injectable Suspension in Rabbits

A Lean Six Sigma Approach to Scleral Buckling Surgery

Area of Disorganization of the Retinal Inner Layers (DRIL) as a Quantitative Biomarker in Eyes with Diabetic Macular Edema

Treatment Burden and Visual Outcomes in Neovascular Age-Related Macular Degeneration (AMD)

Suprachoroidal Delivery of Suspensions of Tyrosine Kinase Inhibitor, Complement Inhibitor, and Corticosteroid: Preclinical and Clinical Correlates

To View More...

You must be signed into an individual account to use this feature.